scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on optimizing infused therapy delivery, will announce its second quarter 2024 financial results on Wednesday, August 14, 2024. The company's management will host a conference call and audio webcast at 4:30 p.m. ET to discuss the financial results and provide a business update.
Participants can join the call by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13747259. A new Call me™ feature is available to avoid operator wait times. The live webcast and replay can be accessed through the company's website under the Investor Relations section.
scPharmaceuticals Inc. (Nasdaq: SCPH), una società farmaceutica focalizzata sull'ottimizzazione della somministrazione delle terapie infusionali, annuncerà i suoi risultati finanziari del secondo trimestre 2024 mercoledì, 14 agosto 2024. La direzione dell'azienda ospiterà una call e un webcast audio alle 16:30 ET per discutere i risultati finanziari e fornire un aggiornamento sull'attività.
I partecipanti possono unirsi alla chiamata componendo il numero 1-877-407-9208 (nazionale) o 1-201-493-6784 (internazionale), utilizzando il codice conferenza 13747259. È disponibile una nuova funzione Call me™ per evitare i tempi di attesa con l'operatore. Il webcast dal vivo e la registrazione possono essere accessibili attraverso il sito web dell'azienda nella sezione Relazioni con gli Investitori.
scPharmaceuticals Inc. (Nasdaq: SCPH), una compañía farmacéutica enfocada en optimizar la entrega de terapias por infusión, anunciará sus resultados financieros del segundo trimestre de 2024 el miércoles, 14 de agosto de 2024. La dirección de la empresa llevará a cabo una conferencia telefónica y un webcast de audio a las 4:30 p.m. ET para discutir los resultados financieros y proporcionar una actualización de negocios.
Los participantes pueden unirse a la llamada marcando 1-877-407-9208 (nacional) o 1-201-493-6784 (internacional) con el código de conferencia 13747259. Hay disponible una nueva función Call me™ para evitar tiempos de espera con el operador. El webcast en vivo y la repetición se pueden acceder a través del sitio web de la empresa en la sección de Relaciones con Inversores.
scPharmaceuticals Inc. (Nasdaq: SCPH)는 주입 치료 전달 최적화에 중점을 둔 제약 회사로, 2024년 2분기 재무 결과를 2024년 8월 14일 수요일에 발표할 예정입니다. 회사 경영진은 동부 표준시 기준 오후 4시 30분에 재무 결과에 대해 논의하고 사업 업데이트를 제공하기 위해 전화 회의 및 오디오 웹캐스트를 개최할 것입니다.
참가자는 1-877-407-9208 (국내) 또는 1-201-493-6784 (국제)로 전화하여 회의 코드 13747259를 입력하여 통화에 참여할 수 있습니다. 운영자 대기 시간을 피하기 위한 새로운 Call me™ 기능이 제공됩니다. 라이브 웹캐스트 및 재생은 회사 웹사이트의 투자자 관계 섹션을 통해 접근할 수 있습니다.
scPharmaceuticals Inc. (Nasdaq: SCPH), une entreprise pharmaceutique axée sur l'optimisation de l'administration des thérapies par infusion, annoncera ses résultats financiers du deuxième trimestre 2024 le mercredi 14 août 2024. La direction de l'entreprise organisera un appel conférence et un webcast audio à 16h30 heure de l'Est pour discuter des résultats financiers et fournir une mise à jour sur les affaires.
Les participants peuvent rejoindre l'appel en composant le 1-877-407-9208 (national) ou le 1-201-493-6784 (international) avec le code de conférence 13747259. Une nouvelle fonction Call me™ est disponible pour éviter les temps d'attente avec l'opérateur. Le webcast en direct et la rediffusion peuvent être consultés sur le site web de l'entreprise dans la section Relations Investisseurs.
scPharmaceuticals Inc. (Nasdaq: SCPH), ein Pharmaunternehmen, das sich auf die Optimierung der Verabreichung von Infusionstherapien konzentriert, wird am Mittwoch, den 14. August 2024 seine Finanzergebnisse für das zweite Quartal 2024 bekanntgeben. Das Management des Unternehmens wird um 16:30 Uhr ET eine Telefonkonferenz und einen Audio-Webcast abhalten, um die Finanzergebnisse zu besprechen und ein Geschäft-Update zu geben.
Teilnehmer können sich über die Nummer 1-877-407-9208 (inland) oder 1-201-493-6784 (international) mit dem Konferenzcode 13747259 in die Konferenz einwählen. Eine neue Call me™-Funktion steht zur Verfügung, um Wartezeiten bei der Verbindung zu vermeiden. Der Live-Webcast und die Wiederholung sind über die Website des Unternehmens im Bereich Investor Relations zugänglich.
- None.
- None.
Management to host conference call and webcast at 4:30 p.m. ET
BURLINGTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, August 14, 2024, to discuss the financial results for the second quarter 2024 and provide a business update.
Participants should dial 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13747259.
To access the new Call me™ feature, which avoids having to wait for an operator, click here.
The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com
Investors:
PJ Kelleher
LifeSci Advisors, 617-430-7579
pkelleher@lifesciadvisors.com
FAQ
When will scPharmaceuticals (SCPH) release its Q2 2024 financial results?
What time is scPharmaceuticals' (SCPH) Q2 2024 earnings call scheduled for?
How can investors access scPharmaceuticals' (SCPH) Q2 2024 earnings call?
Where can I find the replay of scPharmaceuticals' (SCPH) Q2 2024 earnings call?
